# US 2025/0025615 A1 · New dialysis fluid

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2025/0025615 A1
- Document ID: US20250025615A1
- Status: Published application
- Kind: A1
- Application number: 18/716,071
- Filed: 2022-11-29
- Published: 2025-01-23
- Earliest claimed: 2021-12-01
- Assignees: Gambro Lundia AB
- Applicants: Gambro Lundia AB
- Inventors: Sture HOBRO; Anders NILSSON
- Web page: https://patentgrep.com/patent/US20250025615A1

## CPC

- A61M 1/287: {Dialysates therefor}
- A61K 31/19: Carboxylic acids, e.g. valproic acid (salicylic acid A61K31/60)
- A61K 31/198: Alpha-amino acids, e.g. alanine or edetic acid [EDTA] (betaine A61K31/205; proline A61K31/401; tryptophan A61K31/405; histidine A61K31/4172; peptides not degraded to individual amino acids A61K38/00)
- A61K 31/22: of acyclic acids, e.g. pravastatin
- A61K 31/7004: Monosaccharides having only carbon, hydrogen and oxygen atoms
- A61K 47/10: Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
- A61K 47/42: Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein (oligopeptides having up to five amino acids {A61K47/183}; polyamino acids A61K47/34)
- A61P 35/00: Antineoplastic agents
- A61M: DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY (introducing media into or onto the bodies of animals A61D7/00; means for inserting tampons A61F13/26; devices for administering food or medicines orally A61J; containers for collecting, storing or administering blood or medical fluids A61J1/05); DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY (surgery A61B; chemical aspects of surgical articles A61L); DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR {(Electrotherapy, e.g. producing anaesthesia by the use of alternating or intermittent currents A61N1/36021)}
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS

## Abstract

The present application provides a dialysis fluid comprising ketone bodies such as acetoacetate, beta-hydroxybutyrate or pharmaceutically acceptable derivatives, esters and salts thereof, for use in a peritoneal dialysis therapy method of treating cancer.

## Claims

### Claim 1

A dialysis fluid comprising ketone bodies such as acetoacetate, beta-hydroxybutyrate or pharmaceutically acceptable derivatives, esters and salts thereof, for use in a peritoneal dialysis therapy method of treating cancer.

### Claim 2 (depends on 1)

A dialysis fluid according to claim 1, further comprising bicarbonate ions.

### Claim 3 (depends on 1)

A dialysis fluid according to claim 1, wherein the concentration of ketone bodies amounts to 1-15 mM.

### Claim 4 (depends on 3)

A dialysis fluid according to claim 3, wherein the concentration of ketone bodies amounts to 2-12 mM.

### Claim 5 (depends on 1)

A dialysis fluid according to claim 1, wherein the concentration of bicarbonate ions amounts to 15-50 mM.

### Claim 6 (depends on 5)

A dialysis fluid according to claim 5, wherein the concentration of bicarbonate ions amounts to 20-40 mM.

### Claim 7 (depends on 1)

A dialysis fluid according to claim 1, wherein the sum of the concentrations of glucose, pyruvic acid, and hydrolysis-equivalent concentrations of amino acids selected from the group of serine, cysteine, glycine, alanine, glutamic acid, glutamine, proline, aspartic acid, asparagine, threonine and derivatives thereof, amounts to at most 3.3 mM.

### Claim 8 (depends on 7)

A dialysis fluid according to claim 7, wherein said fluid does not contain any pyruvic acid, serine, cysteine, glutamic acid, proline aspartic acid, asparagine, threonine or derivatives thereof.

### Claim 9 (depends on 8)

A dialysis fluid according to claim 8, wherein said fluid contains a hydrolysis-equivalent concentration of at most 0.3 mM glutamine or derivatives thereof.

### Claim 10 (depends on 1)

A dialysis fluid according to claim 1, wherein said fluid also contains a pharmaceutically acceptable amount of a pharmaceutically acceptable cytostatic agent.

### Claim 11 (depends on 1)

A dialysis fluid according to claim 1, wherein the liquid also contains an osmotic agent, selected from the group of polyethylene glycols and albumin.
